IMMUNE ALGORITHMICS
  • Home
  • Science
  • Team
  • Contact
  • Blog
  • Webmail

Blog

oia signs collaboration and commercial agreement with the nhs

15/6/2020

 
Picture
Picture
We are thrilled to announce that Oxford Immune Algorithmics signed last week a collaboration and commercial agreement with the National Health Service in the UK to serve and continue co-developing Algocyte® in Addenbrooke's Hospital at the Cambridge University Hospitals NHS Foundation Trust, one of the most important hospitals in the UK.

Algocyte
® will be deployed at the Department of Paediatric Haematology, Oncology and Palliative Care to help paediatric cancer patients to get supportive monitoring while preventing them to visit the hospital where they are exposed to greater risk of infection due to COVID-19.

​We want to thank partners, collaborators and investors that made this possible believing in us and supporting our project to help clinicians and these vulnerable patients.

Comments are closed.

    Archives

    March 2021
    February 2021
    January 2021
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    May 2019
    April 2019
    March 2019
    January 2019

    RSS Feed

Picture
Picture
A 50 game-changers company

Copyright © 2020 - 2021
​Oxford Immune Algorithmics Ltd
Privacy Policy
Terms and Conditions
  • Home
  • Science
  • Team
  • Contact
  • Blog
  • Webmail